[Correspondence] Chagas disease cardiomyopathy treatment remains a challenge – Authors’ reply
We appreciate Edimar Bocchi’s Correspondence on our Seminar1 on Chagas disease. We agree that the paucity of clinical trials for this disease prevents us from making firm recommendations on specific aspects of this parasitosis. Thus, more often than is desirable, we are obliged to base our practice on prospective observational studies or expert opinion. Unfortunately, this predicament is not unique to Chagas disease.